Dr. Jacinto Obregon, MD

NPI: 1396936019
Total Payments
$1,588
2024 Payments
$1,318
Companies
19
Transactions
73
Medicare Patients
971
Medicare Billing
$101,235

Payment Breakdown by Category

Food & Beverage$1,588 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,588 73 100.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $460.21 10 $0 (2024)
Lilly USA, LLC $200.84 10 $0 (2024)
ABBVIE INC. $146.80 13 $0 (2024)
Janssen Pharmaceuticals, Inc $105.94 7 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $101.84 5 $0 (2024)
PFIZER INC. $95.37 4 $0 (2024)
AstraZeneca Pharmaceuticals LP $70.10 2 $0 (2024)
Amgen Inc. $58.86 4 $0 (2024)
Dexcom, Inc. $57.46 3 $0 (2024)
Ultragenyx Pharmaceutical Inc. $46.11 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,318 70 Novo Nordisk Inc ($245.21)
2020 $102.60 1 Novo Nordisk Inc ($102.60)
2019 $54.30 1 AstraZeneca Pharmaceuticals LP ($54.30)
2018 $112.40 1 Novo Nordisk Inc ($112.40)

All Payment Transactions

73 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/26/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $26.60 General
Category: Diabetes
12/26/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $18.61 General
Category: Neuromodulation
12/05/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.90 General
Category: Diabetes
12/05/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $5.32 General
Category: NEUROSCIENCE
12/05/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $1.35 General
Category: NEUROSCIENCE
11/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $20.30 General
Category: DIABETES
11/15/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $5.41 General
Category: NEUROSCIENCE
11/14/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $17.04 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/12/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $15.53 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
11/11/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $17.98 General
Category: Diabetes
11/04/2024 Hologic Sales and Service, LLC APTIMA (Device) Food and Beverage In-kind items and services $20.33 General
Category: Diagnostics
10/28/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $20.28 General
Category: DIABETES
10/23/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $101.32 General
Category: Obesity
10/23/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $6.90 General
Category: NEUROSCIENCE
10/09/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $16.67 General
Category: Endocrinology
10/01/2024 Lilly USA, LLC Food and Beverage In-kind items and services $14.57 General
09/26/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $24.64 General
Category: Diabetes
09/12/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $9.86 General
Category: NEUROSCIENCE
09/06/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $24.39 General
Category: Diabetes
09/05/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $17.70 General
Category: Endocrinology
08/30/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $18.24 General
Category: Obesity
08/23/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $24.05 General
Category: Diabetes
08/20/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $28.09 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/16/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $13.13 General
Category: Neuroscience
08/14/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.55 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 224 335 $71,081 $23,739
2022 3 223 343 $68,823 $24,264
2021 3 238 411 $78,851 $28,162
2020 3 286 454 $86,065 $25,069
Total Patients
971
Total Services
1,543
Medicare Billing
$101,235
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 119 229 $47,861 $12,867 26.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 67 67 $14,673 $8,280 56.4%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 11 11 $4,301 $1,381 32.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 27 28 $4,246 $1,210 28.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 117 229 $47,861 $14,265 29.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 62 62 $13,578 $7,841 57.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 44 52 $7,384 $2,159 29.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 106 238 $49,742 $15,470 31.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 59 59 $12,921 $7,609 58.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 73 114 $16,188 $5,084 31.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 112 235 $49,115 $11,868 24.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 76 76 $16,644 $8,569 51.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 98 143 $20,306 $4,633 22.8%

About Dr. Jacinto Obregon, MD

Dr. Jacinto Obregon, MD is a Family Medicine healthcare provider based in Gatesville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396936019.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacinto Obregon, MD has received a total of $1,588 in payments from pharmaceutical and medical device companies, with $1,318 received in 2024. These payments were reported across 73 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,588).

As a Medicare-enrolled provider, Obregon has provided services to 971 Medicare beneficiaries, totaling 1,543 services with total Medicare billing of $101,235. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Gatesville, TX
  • Active Since 08/07/2007
  • Last Updated 01/07/2021
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1396936019

Products in Payments

  • JARDIANCE (Drug) $228.76
  • Ozempic (Drug) $210.36
  • Wegovy (Drug) $137.45
  • Victoza (Drug) $112.40
  • SPRAVATO (Drug) $105.94
  • QULIPTA (Drug) $98.16
  • ELIQUIS (Drug) $95.37
  • MOUNJARO (Drug) $59.35
  • Otezla (Drug) $58.86
  • Dexcom G6 Transmitter (Medical Supply) $57.46
  • Crysvita (Drug) $46.11
  • UBRELVY (Drug) $41.49
  • Veozah (Drug) $39.75
  • JORNAY PM (Drug) $36.90
  • Kerendia (Drug) $33.23
  • PROCLAIM (Device) $32.80
  • VANTA ADAPTIVESTIM (Device) $30.94
  • APTIMA (Device) $20.33
  • VOQUEZNA (Drug) $18.10
  • GARDASIL (Biological) $16.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Gatesville